192 related articles for article (PubMed ID: 15607313)
1. Clinical significance and prognostic value of urinary nucleosides in breast cancer patients.
Zheng YF; Kong HW; Xiong JH; Lv S; Xu GW
Clin Biochem; 2005 Jan; 38(1):24-30. PubMed ID: 15607313
[TBL] [Abstract][Full Text] [Related]
2. Study of urinary nucleosides as biological marker in cancer patients analyzed by micellar electrokinetic capillary chromatography.
Zheng YF; Xu GW; Liu DY; Xiong JH; Zhang PD; Zhang C; Yang Q; Lv S
Electrophoresis; 2002 Dec; 23(24):4104-9. PubMed ID: 12481266
[TBL] [Abstract][Full Text] [Related]
3. [Significance of urinary nucleosides in diagnosis of gastric carcinoma].
Chen YJ; Zheng YF; Wang NF; Lu S; Pang T; Yang Q; Xu GW
Ai Zheng; 2003 May; 22(5):537-40. PubMed ID: 12753721
[TBL] [Abstract][Full Text] [Related]
4. Excretion pattern investigation of urinary normal and modified nucleosides of breast cancer patients by RP-HPLC and factor analysis method.
Xu G; Schmid HR; Lu X; Liebich HM; Lu P
Biomed Chromatogr; 2000 Nov; 14(7):459-63. PubMed ID: 11113924
[TBL] [Abstract][Full Text] [Related]
5. [Application of urinary nucleosides in the diagnosis and surgical monitoring of colorectal cancer].
Feng B; Zheng MH; Zheng YF; Lu AG; Li JW; Wang ML; Ma JJ; Xu GW; Yu BM
Zhonghua Wai Ke Za Zhi; 2005 May; 43(9):564-8. PubMed ID: 15938925
[TBL] [Abstract][Full Text] [Related]
6. Analysis of urinary nucleosides as potential tumor markers in human colorectal cancer by high performance liquid chromatography/electrospray ionization tandem mass spectrometry.
Hsu WY; Chen WT; Lin WD; Tsai FJ; Tsai Y; Lin CT; Lo WY; Jeng LB; Lai CC
Clin Chim Acta; 2009 Apr; 402(1-2):31-7. PubMed ID: 19135043
[TBL] [Abstract][Full Text] [Related]
7. Normal and modified urinary nucleosides represent novel biomarkers for colorectal cancer diagnosis and surgery monitoring.
Feng B; Zheng MH; Zheng YF; Lu AG; Li JW; Wang ML; Ma JJ; Xu GW; Liu BY; Zhu ZG
J Gastroenterol Hepatol; 2005 Dec; 20(12):1913-9. PubMed ID: 16336453
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of urinary nucleosides in breast cancer patients before and after tumor removal.
Cho SH; Choi MH; Lee WY; Chung BC
Clin Biochem; 2009 Apr; 42(6):540-3. PubMed ID: 19186175
[TBL] [Abstract][Full Text] [Related]
9. Bioinformatical evaluation of modified nucleosides as biomedical markers in diagnosis of breast cancer.
Bullinger D; Fröhlich H; Klaus F; Neubauer H; Frickenschmidt A; Henneges C; Zell A; Laufer S; Gleiter CH; Liebich H; Kammerer B
Anal Chim Acta; 2008 Jun; 618(1):29-34. PubMed ID: 18501242
[TBL] [Abstract][Full Text] [Related]
10. Analysis, identification and determination of urinary modified nucleosides of cancer and AIDS patients.
Nakano K; Yasaka T; Nakao T; Schram KH; Hammargren WM
Nucleic Acids Symp Ser; 1990; (22):31-2. PubMed ID: 2101906
[TBL] [Abstract][Full Text] [Related]
11. Altered levels of nucleoside metabolite profiles in urogenital tract cancer measured by capillary electrophoresis.
Szymańska E; Markuszewski MJ; Markuszewski M; Kaliszan R
J Pharm Biomed Anal; 2010 Dec; 53(5):1305-12. PubMed ID: 20719449
[TBL] [Abstract][Full Text] [Related]
12. Nucleoside excretion in breast cancer: comparison with other biochemical tumour-index-substances.
Coombes RC; Powles TJ; Gehrke CW; Waalkes TP; Neville AM
Invest Cell Pathol; 1979; 2(1):11-4. PubMed ID: 511604
[TBL] [Abstract][Full Text] [Related]
13. Comparison of triple-negative and estrogen receptor-positive/progesterone receptor-positive/HER2-negative breast carcinoma using quantitative fluorine-18 fluorodeoxyglucose/positron emission tomography imaging parameters: a potentially useful method for disease characterization.
Basu S; Chen W; Tchou J; Mavi A; Cermik T; Czerniecki B; Schnall M; Alavi A
Cancer; 2008 Mar; 112(5):995-1000. PubMed ID: 18098228
[TBL] [Abstract][Full Text] [Related]
14. Multilayer perceptron tumour diagnosis based on chromatography analysis of urinary nucleosides.
Seidel P; Seidel A; Herbarth O
Neural Netw; 2007 Jul; 20(5):646-51. PubMed ID: 17275256
[TBL] [Abstract][Full Text] [Related]
15. [Lung cancer diagnosis based on urinary modified nucleoside metabolic profiling].
Wang WZ; Zhao XJ; Li X; Chen J; Li FL; Xu GW
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2007 Dec; 29(6):738-41. PubMed ID: 18595249
[TBL] [Abstract][Full Text] [Related]
16. Primary and metastatic ovarian cancer in patients with prior breast carcinoma. Pre-operative markers and treatment results.
Tserkezoglou A; Kontou S; Hadjieleftheriou G; Apostolikas N; Vassilomanolakis M; Sikiotis K; Salamalekis E; Tseke P; Magiakos G
Anticancer Res; 2006; 26(3B):2339-44. PubMed ID: 16821613
[TBL] [Abstract][Full Text] [Related]
17. Direct determination of nucleosides in the urine of patients with breast cancer using column-switching liquid chromatography-tandem mass spectrometry.
Cho SH; Jung BH; Lee SH; Lee WY; Kong G; Chung BC
Biomed Chromatogr; 2006 Nov; 20(11):1229-36. PubMed ID: 16799933
[TBL] [Abstract][Full Text] [Related]
18. Urinary nucleosides based potential biomarker selection by support vector machine for bladder cancer recognition.
Mao Y; Zhao X; Wang S; Cheng Y
Anal Chim Acta; 2007 Aug; 598(1):34-40. PubMed ID: 17693304
[TBL] [Abstract][Full Text] [Related]
19. Gas chromatography/mass spectrometric analysis of urinary nucleosides in cancer patients; potential of modified nucleosides as tumour markers.
Langridge JI; McClure TD; el-Shakawi S; Fielding A; Schram KH; Newton RP
Rapid Commun Mass Spectrom; 1993 Jun; 7(6):427-34. PubMed ID: 8329765
[TBL] [Abstract][Full Text] [Related]
20. A fast capillary electrophoresis method for separation and quantification of modified nucleosides in urinary samples.
Jiang Y; Ma Y
Anal Chem; 2009 Aug; 81(15):6474-80. PubMed ID: 19552424
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]